Van Amerongen lab

Section of Molecular Cytology     -     Swammerdam Institute for Life Sciences     -     University of Amsterdam

Publications

Contributions from lab members are shown in bold. An asterisk (*) indicates an equal contribution/shared authorship.


2018
Wiese KE, Nusse R, van Amerongen R (2018), 'Wnt signalling: conquering complexity', Development 2018 145: dev165902 doi: 10.1242/dev.165902 Published 26 June 2018


2017
van de Moosdijk AA, Fu NY, Rios AC, Visvader JE, van Amerongen R (2017), 'Lineage Tracing of Mammary Stem and Progenitor Cells', Methods Mol Biol. 2017;1501:291-308

Wiese KE, Amante RJ, Vivanco MD, Bentires-Alj M, Iggo RD (2017), 'The ninth ENBDC Weggis meeting: growth and in-depth characterisation of normal and neoplastic breast cells.', Breast Cancer Res. 2017 Aug 22;19(1):96. doi: 10.1186/s13058-017-0891-9

Bindels DS, Haarbosch L, van Weeren L, Postma M, Wiese KE, Mastop M, Aumonier S, Gotthard G, Royant A, Hink MA, Gadella TW Jr. (2017), 'mScarlet: a bright monomeric red fluorescent protein for cellular imaging', Nat Methods. 2017 Jan;14(1):53-56. doi: 10.1038/nmeth.4074. Epub 2016 Nov 21.


2016
Jacobsen A., Heijmans N., Verkaar F., Smit M.J., Heringa J., van Amerongen R.*, Feenstra K.A.* (2016), 'Construction and Experimental Validation of a Petri Net Model of Wnt/β-Catenin Signaling', PLoS ONE 11 (5): e0155743. doi:10.1371/journal.pone.0155743

MC Boelens, M Nethe, S Klarenbeek, JR de Ruiter, E Schut, N Bonzanni, AL Zeeman, E Wientjens, E van der Burg, L Wessels, R van Amerongen, J Jonkers (2016), 'PTEN Loss in E-Cadherin-Deficient Mouse Mammary Epithelial Cells Rescues Apoptosis and Results in Development of Classical Invasive Lobular Carcinoma', Cell Reports 16(8): 2087–2101

Loh KM, van Amerongen R, Nusse R (2016), 'Generating cellular diversity and spatial form: Wnt Signaling and the Evolution of Multicellular Animals', Developmental Cell 38(6): p643–655

van de Moosdijk AAA, van Amerongen R (2016), 'Identification of reliable reference genes for qRT-PCR studies of the developing mouse mammary gland', Scientific Reports 6:35595 DOI: 10.1038/srep35595

Lloyd-Lewis B, van de Moosdijk AAA, Bentires-Alj M, Clarke RB, van Amerongen R (2016), 'Complexity galore: 3D cultures, biomechanics and systems medicine at the eighth ENBDC workshop “Methods in Mammary Gland Development and Cancer”', Breast Cancer Res (2016) 18: 115.


2015
van Amerongen R (2015), 'Lineage Tracing in the Mammary Gland Using Cre/lox Technology and Fluorescent Reporter Alleles', Methods Mol Biol. 2015;1293:187-211

Glukhova MA, Hynes N, Vivanco M dM, van Amerongen R, Clarke RB and Bentires-Alj M (2015), 'The seventh ENBDC workshop on methods in mammary gland development and cancer', Breast Cancer Research 17:119


2014
Green J, Nusse R, van Amerongen R (2014), 'The role of ryk and ror receptor tyrosine kinases in wnt signal transduction.', Cold Spring Harb Perspect Biol. 2014 Feb 1;6(2). pii: a009175.

Rinkevich Y, Montoro DT, Contreras-Trujillo H, Harari-Steinberg O, Newman AM, Tsai JM, Lim X, Van-Amerongen R, Bowman A, Januszyk M, Pleniceanu O, Nusse R, Longaker MT, Weissman IL, Dekel B. (2014), 'In Vivo Clonal Analysis Reveals Lineage-Restricted Progenitor Characteristics in Mammalian Kidney Development, Maintenance, and Regeneration', Cell Rep. 2014 May 22;7(4):1270-83.

Shehata M, van Amerongen R, Zeeman AL, Giraddi RR, Stingl J (2014), 'The influence of tamoxifen on normal mouse mammary gland homeostasis', Breast Cancer Research 2014, 16:411

Kemper K, de Goeje PL, Peeper DS, van Amerongen R (2014), 'Phenotype Switching: Tumor Cell Plasticity as a Resistance Mechanism and Target for Therapy', Cancer Res. 2014 Nov 1;74(21):5937-41. Epub 2014 Oct 15.

van Amerongen R (2014), 'Bipotent mammary stem cells: now in amazing 3D', Breast Cancer Research 2014, 16:480


2013
van Amerongen, R and Berns, A (2013), 'Break the loop, escape the cycle?', EMBO J 32(14): 1967-1969

Lim, X., S. H. Tan, W. L. Koh, R. M. Chau, K. S. Yan, C. J. Kuo, R. van Amerongen, A. M. Klein and R. Nusse (2013), 'Interfollicular epidermal stem cells self-renew via autocrine Wnt signaling ', Science 342(6163): 1226-1230

Volkenstein, S., K. Oshima, S. T. Sinkkonen, C. E. Corrales, S. P. Most, R. Chai, T. A. Jan, R. van Amerongen, A. G. Cheng and S. Heller (2013), 'Transient, afferent input-dependent, postnatal niche for neural progenitor cells in the cochlear nucleus.', Proc Natl Acad Sci U S A 110(35): 14456-14461.

Jan, T. A., R. Chai, Z. N. Sayyid, R. van Amerongen, A. Xia, T. Wang, S. T. Sinkkonen, Y. A. Zeng, J. R. Levin, S. Heller, R. Nusse and A. G. Cheng (2013), 'Tympanic border cells are Wnt-responsive and can act as progenitors for postnatal mouse cochlear cells.', Development 140(6): 1196-1206.

Bowman, A. N., van Amerongen, R, Palmer, TD and Nusse, R (2013), 'Lineage tracing with Axin2 reveals distinct developmental and adult populations of Wnt/beta-catenin-responsive neural stem cells.', Proc Natl Acad Sci U S A 110(18): 7324-7329.


2012
van Amerongen, R., A. N. Bowman and R. Nusse (2012), 'Developmental stage and time dictate the fate of Wnt/beta-catenin-responsive stem cells in the mammary gland.', Cell Stem Cell 11(3): 387-400.

van Amerongen, R., C. Fuerer, M. Mizutani and R. Nusse (2012), 'Wnt5a can both activate and repress Wnt/beta-catenin signaling during mouse embryonic development.', Dev Biol 369(1): 101-114.

van Amerongen, R. (2012), 'Alternative Wnt pathways and receptors.', Cold Spring Harb Perspect Biol 4(10).

Verkaar, F., K. M. Cadigan and R. van Amerongen (2012), 'Celebrating 30 years of Wnt signaling.', Sci Signal 5(254): mr2.

Walf-Vorderwulbecke, V., J. de Boer, S. J. Horton, R. van Amerongen, N. Proost, A. Berns and O. Williams (2012), 'Frat2 mediates the oncogenic activation of Rac by MLL fusions.', Blood 120(24): 4819-4828.


2010
van Amerongen, R., M. C. Nawijn, J. P. Lambooij, N. Proost, J. Jonkers and A. Berns (2010), 'Frat oncoproteins act at the crossroad of canonical and noncanonical Wnt-signaling pathways.', Oncogene 29(1): 93-104.


2009
van Amerongen, R. and R. Nusse (2009), 'Towards an integrated view of Wnt signaling in development.', Development 136(19): 3205-3214.


2008
van Amerongen, R., A. Mikels and R. Nusse (2008), 'Alternative wnt signaling is initiated by distinct receptors.', Sci Signal 1(35): re9.

van Amerongen, R. and A. Berns (2008), 'Targeted anticancer therapies: mouse models help uncover the mechanisms of tumor escape.', Cancer Cell 13(1): 5-7.


2006
van Amerongen, R. and A. Berns (2006), 'TXR1-mediated thrombospondin repression: a novel mechanism of resistance to taxanes?', Genes Dev 20(15): 1975-1981.

van Amerongen, R. and A. Berns (2006), 'Knockout mouse models to study Wnt signal transduction.', Trends Genet 22(12): 678-689.


2005
van Amerongen, R. and A. Berns (2005), 'Re-evaluating the role of Frat in Wnt-signal transduction.', Cell Cycle 4(8): 1065-1072.

van Amerongen, R., M. Nawijn, J. Franca-Koh, J. Zevenhoven, H. van der Gulden, J. Jonkers and A. Berns (2005), 'Frat is dispensable for canonical Wnt signaling in mammals.', Genes Dev 19(4): 425-430.


prior to 2005
van Amerongen, R., H. van der Gulden, F. Bleeker, J. Jonkers and A. Berns (2004), 'Characterization and functional analysis of the murine Frat2 gene.', J Biol Chem 279(26): 26967-26974.

Scheffer, G. L., A. W. Reurs, B. Jutten, S. H. Beiboer, R. van Amerongen, M. Schoester, E. A. Wiemer, H. R. Hoogenboom and R. J. Scheper (2002), 'Selection and characterisation of a phage-displayed human antibody (Fab) reactive to the lung resistance-related major vault protein.', Br J Cancer 86(6): 954-962.

Chan, M. F.*, R. van Amerongen*, T. Nijjar, E. Cuppen, P. A. Jones and P. W. Laird (2001), 'Reduced rates of gene loss, gene silencing, and gene mutation in Dnmt1-deficient embryonic stem cells.', Mol Cell Biol 21(22): 7587-7600.

Jonkers, J., R. van Amerongen, M. van der Valk, E. Robanus-Maandag, M. Molenaar, O. Destree and A. Berns (1999), 'In vivo analysis of Frat1 deficiency suggests compensatory activity of Frat3.', Mech Dev 88(2): 183-194.